封面
市場調查報告書
商品編碼
1690365

血糖監測系統市場報告:2031 年趨勢、預測與競爭分析

Blood Glucose Monitoring System Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球血糖監測系統市場前景光明,指尖和替代站點市場充滿機會。預計到 2031 年,全球血糖監測系統市場規模將達到 371 億美元,2025 年至 2031 年的複合年成長率為 7.5%。這個市場的主要促進因素是糖尿病盛行率的上升、人口老化導致的糖尿病易感性增加、新產品的發布以及人們對糖尿病預防意識的不斷提高。

  • Lucintel 表示,基於患者護理環境,由於糖尿病患者數量的增加以及人們對定期血糖監測的認知的提高,預計居家醫療在預測期內仍將是最大的細分市場。
  • 在測試站點類別中,指尖測試由於其高準確性和可靠性預計將繼續佔據最大的佔有率。
  • 根據地區分類,由於肥胖率上升、醫療保健成本高、新產品推出以及技術進步,預計北美在預測期內仍將是最大的地區。

血糖監測系統市場的策略性成長機會

從策略角度來看,血糖監測系統市場在關鍵應用領域提供了許多成長機會。摘要如下:

  • 糖尿病管理:糖尿病管理:採用先進的血糖監測系統進行糖尿病管理帶來了成長機會。這些系統提供即時資料和見解,以更好地管理和治療糖尿病。
  • 與遠端醫療的整合:將血糖監測系統與遠端醫療平台結合也可以開闢成長前景。這使得遠端監控和諮詢成為可能,從而提高了護理品質和患者管理。
  • 提供可負擔的監測解決方案:為低收入和發展中地區開發可負擔的血糖監測設備代表著一個巨大的成長機會。這些解決方案將擴大糖尿病管理工具的使用範圍並改善全球健康。
  • 穿戴式科技:將血糖監測系統與穿戴式科技結合,開啟了成長潛力。穿戴式裝置支援持續血糖監測以及其他健康指標,促進全面的健康管理。
  • 個人化醫療:血糖監測資料具有成長機會,可支援個人化醫療。根據個人血糖模式和反應制定糖尿病管理方案可提高治療效果和患者預後。

這些新機會正在推動市場成長和發展,提高血糖監測系統的有效性和採用率。

血糖監測系統市場促進因素與挑戰

血糖監測系統市場是一個不斷成長的市場,其成長潛力受到各種技術、經濟和監管因素的影響。以下是一些關鍵促進因素和挑戰:

推動血糖監測系統市場發展的因素有:

  • 技術進步:CGM 和非侵入性血糖監測技術的改進和創新提高了使用者的準確性和便利性。這推動了市場的成長。
  • 糖尿病盛行率不斷上升:全球糖尿病盛行率的上升推動了對有效血糖監測解決方案的需求成長,進一步促進了市場擴張。
  • 融入數位健康:血糖監測儀擴大融入數位健康平台,增強資料管理和病人參與,從而支持市場成長。
  • 專注於個人化:個人化醫療和個人化治療計劃的進步推動了對先進血糖監測系統的需求。
  • 經濟實惠的解決方案:具有成本效益的血糖監測設備的開發正在擴大市場准入並刺激服務不足地區的成長。

血糖監測系統市場面臨的挑戰是:

  • 高成本:先進的血糖監測系統價格昂貴,採用有限,尤其是在低收入和用戶人群中。
  • 監管障礙:獲得新技術的核准可能很複雜且耗時,這可能會延遲產品發布和市場進入。

這些市場促進因素和挑戰將繼續影響血糖監測系統市場,塑造其成長軌跡和相關人員的策略決策。

目錄

第1章執行摘要

第2章全球血糖監測系統市場:市場動態

  • 簡介、背景和分類
  • 供應鏈
  • 產業驅動力與挑戰

第3章市場趨勢與預測分析(2019-2031)

  • 宏觀經濟趨勢(2019-2024)及預測(2025-2031)
  • 全球血糖監測系統市場趨勢(2019-2024)及預測(2025-2031)
  • 全球血糖監測系統市場(按測試站點)
    • 指尖
    • 替代網站
  • 全球血糖監測系統市場(按產品)
    • 自我監控
    • 連續血糖監測裝置
  • 全球血糖監測系統市場(依病患照護環境)
    • 醫院
    • 居家醫療
  • 全球血糖監測系統市場(按應用)
    • 1型糖尿病
    • 2型糖尿病
    • 妊娠糖尿病
    • 其他

第4章區域市場趨勢與預測分析(2019-2031)

  • 全球血糖監測系統市場(按地區)
  • 北美血糖監測系統市場
  • 歐洲血糖監測系統市場
  • 亞太血糖監測系統市場
  • 世界其他地區血糖監測系統市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球血糖監測系統市場成長機會(按測試站點)
    • 全球血糖監測系統市場成長機會(按產品)
    • 全球血糖監測系統市場的成長機會(依病患照護環境)
    • 全球血糖監測系統市場成長機會(按應用)
    • 全球血糖監測系統市場各區域成長機會
  • 全球血糖監測系統市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球血糖監測系統市場產能擴張
    • 全球血糖監測系統市場的企業合併
    • 認證和許可

第7章主要企業簡介

  • Thermos Fisher Scientific
  • Promega
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • BD
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott
簡介目錄

The future of the global blood glucose monitoring system market looks promising with opportunities in the fingertip and alternate site markets. The global blood glucose monitoring system market is expected to reach an estimated $37.1 billion by 2031 with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the growing prevalence of diabetes, the aging population's increased susceptibility to the disease, as well as, raising awareness of new product releases and diabetes prevention.

  • Lucintel forecasts that, within the patient care setting category, homecare will remain the largest segment over the forecast period due to the rising number of diabetic patients and increasing awareness about regular monitoring of glucose levels.
  • Within the testing site category, fingertip testing will remain the largest segment due to high accuracy and high reliability.
  • In terms of regions, North America will remain the largest region over the forecast period due to rising rates of obesity, expensive medical care, new product introductions, and technology improvements in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Blood Glucose Monitoring System Market

The blood glucose monitoring system market has created current trends that are shaping its future. Here's an overview:

  • Continuous Glucose Monitoring: Currently, continuous glucose monitoring (CGM) systems are gaining more demand because they offer real-time glucose information and trends. These systems improve diabetes management by continuously presenting glucose levels, thereby reducing the need for multiple fingerstick tests.
  • Integration with Digital Health Platforms: There is an increasing trend of integrating glucose monitoring systems into digital health platforms and apps for better management, analysis, and communication between patients and healthcare professionals.
  • Non-Invasive Technologies: There is significant interest in the development of non-invasive glucose monitoring technologies. These technologies aim to provide accurate glucose measurements without requiring blood samples, making it easier and more comfortable for users.
  • Smartphone Connectivity: Monitors with smartphone connectivity are gaining momentum. These devices allow users to access their glucose levels and manage their data through various mobile applications, facilitating easy access and usability.
  • Affordability: The market is moving towards finding more affordable solutions for monitoring blood glucose. Lower-priced devices are making diabetes management more accessible in poorer and underdeveloped regions worldwide.

These trends act as catalysts for innovation, extending the use of blood glucose monitoring systems and enhancing their role in diabetes management and patient care.

Recent Developments in the Blood Glucose Monitoring System Market

There have been several key developments in the blood glucose monitoring system market. An overview follows:

  • Improving CGM: Continuous glucose monitoring systems now boast better accuracy and extended wear times, providing more detailed glucose data and better support for diabetes management.
  • Non-Invasive Monitoring: Non-invasive glucose monitoring technology is under development, with new devices emerging that reduce the pain and discomfort associated with traditional blood glucose testing.
  • Integration of Glucose Monitors with Mobile Health: Recent innovations include integrating glucose monitors with mobile health apps and platforms. These integrations enhance data tracking and improve interaction between patients and healthcare providers.
  • Cost-Effective Solutions: Novel blood glucose meters are being introduced with a focus on cost-effectiveness. These provide essential features at lower prices, increasing access among larger populations.
  • Improved Accuracy and Precision: Advances in sensor technology are enabling the development of more accurate and precise blood glucose monitoring systems, thereby increasing the reliability of glucose measurements and improving diabetes management.

These developments enhance the functionality of blood glucose monitoring systems by improving accuracy, access, and user convenience in diabetes management.

Strategic Growth Opportunities for Blood Glucose Monitoring System Market

From a strategic perspective, the blood glucose monitoring system market has numerous growth prospects within key applications. A brief overview follows:

  • Management of Diabetes: The adoption of advanced glucose monitoring systems for diabetes management presents a growing opportunity. These systems provide real-time data and insights to better control and treat diabetes.
  • Integration with Telehealth: Integrating blood glucose monitoring systems with telehealth platforms also opens up growth prospects. This enables remote monitoring and consultations, improving the quality of care and patient management.
  • Offering Monitoring Solutions at Affordable Prices: Developing affordable glucose monitoring devices for low-income and developing regions represents a significant growth opportunity. These solutions will broaden access to diabetes management tools and improve global health outcomes.
  • Wearable Technology: Integrating glucose monitoring systems with wearable technology opens potential avenues for growth. Wearable devices support continuous glucose monitoring along with other health metrics, facilitating comprehensive health management.
  • Personalized Medicine: There are growth opportunities in glucose monitoring data that support personalized medicine. Tailoring diabetes management to individual glucose patterns and responses enhances treatment effectiveness and patient outcomes.

These emerging opportunities are fostering market growth and development, and improving the efficacy and reach of blood glucose monitoring systems.

Blood Glucose Monitoring System Market Driver and Challenges

The blood glucose monitoring system market is a growth market exhibiting possibilities for growth that are influenced by various technological, economic, and regulatory factors. A glance at the key drivers and challenges has been presented here:

The factors responsible for driving the blood glucose monitoring system market include:

  • Technological Advances: Improvement and innovation in monitoring technologies of glucose, both CGM and non-obtrusive, better the accuracy and convenience for the user. This acts as a driver to market growth.
  • Growing Diabetes Prevalence: The rise in global prevalence propels the growth in demand for effective glucose monitoring solutions, further supporting the market's expansion.
  • Integration into Digital Health: Glucose monitors are increasingly being integrated into digital health platforms, enhancing data management and patient engagement, hence assisting the market to grow.
  • More Emphasis on Personalization: Advancing personalized medicine and personalized treatment plans is driving the need for advanced glucose monitoring systems.
  • Affordable Solutions: The development of cost-effective glucose monitoring devices is expanding market access and driving growth in underserved regions.

Challenges in the blood glucose monitoring system market are:

  • High Costs: Advanced glucose monitoring systems are expensive, and their adoption is particularly low in low-income regions and among non-insured populations.
  • Regulatory Hurdles: Navigating regulatory approvals for new technologies can be complex and time-consuming, potentially delaying product launches and market entry.

These drivers and challenges will continue to influence the blood glucose monitoring system market and shape its growth trajectory and strategic decisions of the stakeholders.

List of Blood Glucose Monitoring System Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, blood glucose monitoring system companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the blood glucose monitoring system companies profiled in this report include-

  • Thermos Fisher Scientific
  • Promega
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Blood Glucose Monitoring System by Segment

The study includes a forecast for the global blood glucose monitoring system market by testing site, product, patient care setting, application, and region.

Blood Glucose Monitoring System Market by Testing Site [Analysis by Value from 2019 to 2031]:

  • Fingertip
  • Alternate Site

Blood Glucose Monitoring System Market by Product [Analysis by Value from 2019 to 2031]:

  • Self-Monitoring
  • Continuous Glucose Monitoring Devices

Blood Glucose Monitoring System Market by Patient Care Setting [Analysis by Value from 2019 to 2031]:

  • Hospital
  • Homecare

Blood Glucose Monitoring System Market by Application [Analysis by Value from 2019 to 2031]:

  • Type 1
  • Type 2
  • Gestational Diabetes
  • Others

Blood Glucose Monitoring System Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Blood Glucose Monitoring System Market

Blood glucose monitoring systems represent one of the fastest-growing markets, replacing conventional products with technologically advanced ones and increasing demand for diabetes management. Here is an overview of recent trends in major countries:

  • United States: The introduction of real-time continuous glucose monitoring systems that deliver real-time glucose readings marks a significant development in the U.S. market. Integration with smartphones and wearables is continuously modernizing user convenience for easier data access.
  • China: China remains a high-growth market due to the rising penetration of low-cost blood glucose meters and CGMs, driven by greater disease awareness and healthcare reforms. Innovations in lower-cost monitoring solutions are making diabetes management more accessible to a broader population.
  • Germany: Germany is progressing in developing non-invasive glucose monitoring technology and improving the accuracy of glucose testing. Ongoing research aims to increase the reliability of these systems and integrate them into digital health platforms for more effective diabetes management.
  • India: The market is expected to grow due to the introduction of more affordable blood glucose monitoring devices and increased access to continuous glucose monitoring. This will improve accessibility to diabetes management tools in both urban and rural settings.
  • Japan: Japan is at the forefront of integrating other health monitoring technologies into advanced glucose monitoring systems. Its focus is on developing systems capable of providing comprehensive health data, including glucose levels, for personalized treatment plans.

Features of the Global Blood Glucose Monitoring System Market

Market Size Estimates: Blood glucose monitoring system market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Blood glucose monitoring system market size by various segments, such as by testing site, product, patient care setting, application, and region in terms of value ($B).

Regional Analysis: Blood glucose monitoring system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different testing sites, products, patient care settings, applications, and regions for the blood glucose monitoring system market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the blood glucose monitoring system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the blood glucose monitoring system market by testing site (fingertip and alternate site), product (self-monitoring and continuous glucose monitoring devices), patient care setting (hospital and homecare), application (type 1, type 2, gestational diabetes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Blood Glucose Monitoring System Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Blood Glucose Monitoring System Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Blood Glucose Monitoring System Market by Testing Site
    • 3.3.1: Fingertip
    • 3.3.2: Alternate Site
  • 3.4: Global Blood Glucose Monitoring System Market by Product
    • 3.4.1: Self-Monitoring
    • 3.4.2: Continuous Glucose Monitoring Devices
  • 3.5: Global Blood Glucose Monitoring System Market by Patient Care Setting
    • 3.5.1: Hospital
    • 3.5.2: Homecare
  • 3.6: Global Blood Glucose Monitoring System Market by Application
    • 3.6.1: Type 1
    • 3.6.2: Type 2
    • 3.6.3: Gestational Diabetes
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Blood Glucose Monitoring System Market by Region
  • 4.2: North American Blood Glucose Monitoring System Market
    • 4.2.1: North American Market by Testing Site: Fingertip and Alternate Site
    • 4.2.2: North American Market by Patient Care Setting: Hospital and Homecare
  • 4.3: European Blood Glucose Monitoring System Market
    • 4.3.1: European Market by Testing Site: Fingertip and Alternate Site
    • 4.3.2: European Market by Patient Care Setting: Hospital and Homecare
  • 4.4: APAC Blood Glucose Monitoring System Market
    • 4.4.1: APAC Market by Testing Site: Fingertip and Alternate Site
    • 4.4.2: APAC Market by Patient Care Setting: Hospital and Homecare
  • 4.5: ROW Blood Glucose Monitoring System Market
    • 4.5.1: ROW Market by Testing Site: Fingertip and Alternate Site
    • 4.5.2: ROW Market by Patient Care Setting: Hospital and Homecare

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Testing Site
    • 6.1.2: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Product
    • 6.1.3: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Patient Care Setting
    • 6.1.4: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Application
    • 6.1.5: Growth Opportunities for the Global Blood Glucose Monitoring System Market by Region
  • 6.2: Emerging Trends in the Global Blood Glucose Monitoring System Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Blood Glucose Monitoring System Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Blood Glucose Monitoring System Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermos Fisher Scientific
  • 7.2: Promega
  • 7.3: Agilent Technologies
  • 7.4: Bio-Rad Laboratories
  • 7.5: QIAGEN
  • 7.6: Merck
  • 7.7: B.D.
  • 7.8: Sanofi
  • 7.9: Ascensia Diabetes Care Holdings
  • 7.10: Abbott